#MicroglialSenescence
LightNews LightNews
alicefrolov.bsky.social
Vertical lollipop timeline listing years down the side, with bar length showing annual publications on microglial senescence in neurodegeneration research.

#MicroglialSenescence #Neuroinflammation #AlzheimerDisease #DiseaseAssociatedMicroglia #Bibliometrics #NeurodegenerationResearch #Gliobiology
Figure: Microglial senescence papers have climbed steeply since 2000 I am sharing a bibliometric view of how the literature linking microglia, ageing or senescence, and neurodegeneration has developed. The chart is a vertical year-ladder lollipop timeline: each year from 2000 to 2025 is a rung, stem length is proportional to the annual PubMed record count, and the peak year is accented. Data come from PubMed (NCBI E-utilities) using microglia[tiab] AND (senescence[tiab] OR senescent[tiab] OR aging[tiab] OR ageing[tiab]) AND (neurodegeneration[tiab] OR Alzheimer[tiab]), yielding 1,658 records in total, and these counts reflect indexing and query wording, not research effort or quality. The series begins at 3 records in 2000 and reaches 197 in 2025, which is also the peak year. That corresponds to a 65.7-fold increase, with a mean annual growth of 18.2%. The rise is steady rather than driven by a single outlier year, which is why the ladder form is useful: the lengthening stems make the cumulative shift readable without smoothing. The increase is temporally associated with a broader conceptual shift in the field. Microglia are increasingly described in terms of replicative exhaustion, CDKN2A-linked cell cycle arrest, the senescence-associated secretory phenotype, impaired phagocytic clearance and altered lipid handling, alongside disease-associated microglial states. Whether these descriptions converge on a single senescent phenotype or reflect partially overlapping activation programmes is not something this record count can resolve. The query also captures papers that use ageing as a covariate rather than as a mechanistic variable, so precision for true senescence studies is likely imperfect. Open questions for colleagues: how should keyword-based retrieval be reconciled with marker-based definitions of senescent microglia, and would restricting to title or abstract mentions of specific effectors change the trajectory? Figure: Microglial senescence papers have climbed steeply since 2000 I am sharing a bibliometric view of how the literature linking microglia, ageing or senescence, and neurodegeneration has developed. The chart is a vertical year-ladder lollipop timeline: each year from 2000 to 2025 is a rung, stem length is proportional to the annual PubMed record count, and the peak year is accented. Data come from PubMed (NCBI E-utilities) using microglia[tiab] AND (senescence[tiab] OR senescent[tiab] OR aging[tiab] OR ageing[tiab]) AND (neurodegeneration[tiab] OR Alzheimer[tiab]), yielding 1,658 records in total, and these counts reflect indexing and query wording, not research effort or quality. The series begins at 3 records in 2000 and reaches 197 in 2025, which is also the peak year. That corresponds to a 65.7-fold increase, with a mean annual growth of 18.2%. The rise is steady rather than driven by a single outlier year, which is why the ladder form is useful: the lengthening stems make the cumulative shift readable without smoothing. The increase is temporally associated with a broader conceptual shift in the field. Microglia are increasingly described in terms of replicative exhaustion, CDKN2A-linked cell cycle arrest, the senescence-associated secretory phenotype, impaired phagocytic clearance and altered lipid handling, alongside disease-associated microglial states. Whether these descriptions converge on a single senescent phenotype or reflect partially overlapping activation programmes is not something this record count can resolve. The query also captures papers that use ageing as a covariate rather than as a mechanistic variable, so precision for true senescence studies is likely imperfect. Open questions for colleagues: how should keyword-based retrieval be reconciled with marker-based definitions of senescent microglia, and would restricting to title or abstract mentions of specific effectors change the trajectory?
November 2, 2026 at 5:35 PM